The global human immunoglobulin market is projected to rise by $9.7b through 2028 at an estimated compound annual growth rate (CAGR) of 10.11%, according to Technavio. The sector’s expansion is ...

Read the Patient Information Leaflet and Instructions for Use if available from your pharmacist before you start using immune globulin and each time you get a refill. If you have any questions ...

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).

This new immunoglobulin (Ig) therapeutic option will expand AIC’s ability to better serve PI patients. “We are excited to add ALGYLO™ to our expansive list of Ig infusion therapies,” said ...